SCHEMBL10083283

SCHEMBL10083283

CS(=O)(=O)c1cccc(C2(C(=O)N[C@H](CN3CCCC3)c3ccccc3)CC2)c1

nearest known ligand 0.42

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
KCNK3 O14649 2/20 0.42
ALDH1A1 P00352 3/20 0.41
GAA P10253 1/20 0.41
CNR2 P34972 1/20 0.40
NPC1 O15118 1/20 0.40
OPRK1 P41145 4/20 0.39
OPRM1 P35372 2/20 0.39
OPRD1 P41143 2/20 0.39
CYP2D6 P10635 1/20 0.39
GPR88 Q9GZN0 1/20 0.39
ROCK2 O75116 1/20 0.39
ROCK1 Q13464 1/20 0.39
KMT2A Q03164 1/20 0.38
L3MBTL1 Q9Y468 1/20 0.38
BDKRB1 P46663 1/20 0.38
CCR2 P41597 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL15380168 0.99 KCNK3 (0.42) KCNK3ALDH1A1GAACNR2NPC1
Hydrochloric Acid SCHEMBL15380169 0.99 KCNK3 (0.42) KCNK3ALDH1A1GAACNR2NPC1
SCHEMBL10083327 0.90 ALDH1A1 (0.44) KCNK3ALDH1A1NPC1OPRK1OPRM1
SCHEMBL10083346 0.89 CCR2 (0.43) ALDH1A1GAANPC1OPRK1OPRM1
SCHEMBL435448 0.89 CCR2 (0.43) ALDH1A1GAANPC1OPRK1OPRM1
SCHEMBL10083993 0.87 OPRK1 (0.47) KCNK3NPC1OPRK1OPRM1OPRD1
SCHEMBL435629 0.87 OPRK1 (0.47) KCNK3NPC1OPRK1OPRM1OPRD1
SCHEMBL10084059 0.86 HDAC4 (0.49) KCNK3ALDH1A1NPC1OPRK1OPRM1
SCHEMBL459729 0.86 GPR88 (0.41) ALDH1A1NPC1OPRK1OPRM1OPRD1
SCHEMBL15380900 0.86 GPR88 (0.41) ALDH1A1NPC1OPRK1OPRM1OPRD1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9303027-B2 Kappa opioid receptor agonists DR. REDDY'S LABORATORIES LTD. (IN) 2016-04-05 US disclosed
US-9303027-B2 Kappa opioid receptor agonists DR. REDDY'S LABORATORIES LTD. (IN) 2016-04-05 US disclosed
US-20130303525-A1 KAPPA OPIOID RECEPTOR AGONISTS DR. REDDY'S LABORATORIES, INC. (US) 2013-11-14 US disclosed
US-20130303525-A1 KAPPA OPIOID RECEPTOR AGONISTS DR. REDDY'S LABORATORIES, INC. (US) 2013-11-14 US disclosed
WO-2012012410-A2 KAPPA OPIOID RECEPTOR AGONISTS DR. REDDY'S LABORATORIES LTD. (IN) 2012-01-26 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130303525-A1 KAPPA OPIOID RECEPTOR AGONISTS OPRK1, OPRL1, OPRD1 KCNK3 172/4885ALDH1A1 1649/4885GAA 4184/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.